Evidence-Based Practice Proposal Section C: Solution Description

Evidence-Based Practice Proposal Section C: Solution Description

Evidence-Based Practice Proposal

Type 1 Diabetes (T1D) is a chronic disease that limits the pancreas from producing enough insulin (Kahanovitz, Sluss & Russell, 2017). Insulin is an essential hormone in the body. It is required to allow sugar or glucose to enter body cells to produce energy. Although T1D is commonly diagnosed in childhood, its incidence has been rising in the elderly population. The condition predisposes them to hypoglycemia, which is associated with seizures, loss of consciousness, and altered mental status. An effective way to manage T1D in the elderly is the application of continuous glucose monitoring (CGM). According to Health Quality Ontario (2018), CGM is more effective than self-monitoring of blood glucose in T1D management. In light of this, the paper describes CGM as the proposed solution, explains how CGM is consistent with the organization’s culture and expounds the expected outcomes. The paper also provides insights on methods used to achieve the outcomes and describes the impact of the outcomes.

Proposed Solution

Several factors, including certain viruses, age, environmental factors, and genetics contribute to T1D. The condition may lead to neuropathy, heart attack, stroke, atherosclerosis, nephropathy, high blood pressure, blindness, skin and mouth infections, and damage to the foot. To manage type 1 diabetes and prevent the mentioned complications, the Managed Care organization should use continuous glucose monitoring strategy on the elderly patients.

CLICK HERE TO PLACE YOUR ORDER

Continuous glucose monitoring tracks blood glucose levels or blood sugar all day (Heinemann & Stuhr, 2018). An individual can see their glucose levels anytime when using a continuous glucose monitoring device. In healthcare organizations, CGM devices can be used to review how a patient’s glucose changes over a specified period; for instance, over a few days or hours to note the trends. As healthcare providers have glances of a patient’s glucose levels in real-time, they can make more informed decisions, such as administering drugs, conducting physical therapy, or balancing the patient’s food (Sørgård, Iversen & Mårtensson, 2019). Elderly patients with T1D are unable to reach or maintain the recommended A1C targets. However, evidence shows that real-time CGM devices potentially help users enhance diabetes control as it reduces hypoglycemic and hyperglycemic exposures (Wood, O’Neal, Furler & Ekinci, 2018). The proposed solution is realistic in the Managed Care organization since staff members are willing to participate and adopt evidence-based practices. Additionally, the organization is knowledgeable and equipped with EBP skills.

Organizational Culture

The organization’s culture acknowledges the adoption of evidence-based practices that help improve the quality of life. Staff members are willing and have the knowledge required in implementing the proposed solution. In the case of healthcare workers displaying resistance, the Managed Care organization has a change champions program that educates about the significance of EBP changes. Additionally, CGM project is consistent with the organization’s resources in that leadership and management provides necessary finances and resources such as electronic devices, computers, and the internet in support of the EBP.

Expected Outcomes

Based on research, the use of continuous glucose monitoring in the organization will address the problem of older adults with type 1 diabetes. CGM will lower hypoglycemia a crucial aspect in T1D management. Thus, minimizing complications associated with hypoglycemia. Also, since the elderly do not recognize signs and symptoms of low or high blood glucose level, CGM will assist providers in determining the appropriate time for medication or balanced diets, hence increasing patient satisfaction Evidence-Based Practice Proposal Section C: Solution Description.

Methods to Achieve Outcomes

Outcomes will be achieved by interprofessional collaboration in the treatment and management of elderly patients with T1D. The interprofessional collaboration will reduce workload or burn-outs when checking real-time data from CGM devices. CGM data will inform healthcare providers about the patient’s glucose trends and levels and the rate of change. Alarms will constitute the second method, through which healthcare providers will be alerted to administer subcutaneous insulin infusion or insulin injection therapies.

Outcome Impact

The outcomes of implementing continuous glucose monitoring will impact quality care improvement. Healthcare providers will provide care that abides by the six domains of quality that comprise timeliness, safety, efficiency, effectiveness, patient-centeredness, and equitability.Through CGM alerts, providers will provide medication on time and generate informed decisionson the effective and patient-centred approach in managing patients’ conditions.

References

Health Quality Ontario. (2018). Continuous monitoring of glucose for type 1 diabetes: a health technology assessment. 
Ontario health technology assessment series
, 
18
(2), 1.

Heinemann, L., & Stuhr, A. (2018). Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future?. 
European Endocrinology
, 
14
(2), 24. doi: 10.17925/ee.2018.14.2.24

Kahanovitz, L., Sluss, P., & Russell, S. (2017). Type 1 Diabetes—A Clinical Perspective. 
Point Of Care: The Journal Of Near-Patient Testing & Technology
, 
16
(1), 37-40. doi: 10.1097/poc.0000000000000125

Sørgård, B., Iversen, M., & Mårtensson, J. (2019). Continuous glucose monitoring in adults with type 1 diabetes: A balance between benefits and barriers: A critical incident study. 
Journal Of Clinical Nursing
, 
28
(17-18), 3318-3329. doi: 10.1111/jocn.14911 Evidence-Based Practice Proposal Section C: Solution Description

Wood, A., O’Neal, D., Furler, J., & Ekinci, E. (2018). Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges. 
Internal Medicine Journal
, 
48
(5), 499-508. doi: 10.1111/imj.13770

Evidence-Based Practice Proposal Section C: Solution Description

Section C: Solution Description

Write a paper of 500-750 words for your proposed evidence-based practice project solution. Address the following criteria:

1. Proposed Solution: (a) Describe the proposed solution (or intervention) for the problem and the way(s) in which it is consistent with current evidence. Heavily reference and provide substantial evidence for your solution or intervention. (b) Consider if the intervention may be unrealistic in your setting, if it may be too costly, or if there is a lack of appropriate training available to deliver the intervention. If the intervention is unrealistic, you may need to go back and make changes to your problem statement before continuing.

2. Organization Culture: Explain the way(s) in which the proposed solution is consistent with the organization or community culture and resources.

3. Expected Outcomes: Explain the expected outcomes of the project. The outcomes should flow from the problem statement.

4. Method to Achieve Outcomes: Develop an outline of how the outcomes will be achieved. List any specific barriers that will need to be assessed and eliminated. Make sure to mention any assumptions or limitations that may need to be addressed.

5. Outcome Impact: Describe the impact the outcomes will have on one or all of the following indicators: quality care improvement, patient-centered quality care, efficiency of processes, environmental changes, or professional expertise.

You are required to cite three to five sources to complete this assignment. Sources must be published within the last 5 years and appropriate for the assignment criteria and nursing content.

This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion
Evidence-Based Practice
Proposal Section C: Solution Description